NCT06925542 A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease Status RECRUITING Phase PHASE1
NCT06492304 A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed/Refractory Hematologic Malignancies Status COMPLETED Phase PHASE1/PHASE2
NCT05356195 Evaluation of Safety and Efficacy of CTX001 in Pediatric Participants With Transfusion-Dependent β-Thalassemia (TDT) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05329649 Evaluation of Safety and Efficacy of CTX001 in Pediatric Participants With Severe Sickle Cell Disease (SCD) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04208529 A Long-term Follow-up Study in Participants Who Received CTX001 Status ENROLLING_BY_INVITATION Phase PHASE3
NCT03745287 A Safety and Efficacy Study Evaluating CTX001 in Subjects With Severe Sickle Cell Disease Status COMPLETED Phase PHASE2/PHASE3
NCT03655678 A Safety and Efficacy Study Evaluating CTX001 in Participants With Transfusion-Dependent β-Thalassemia Status COMPLETED Phase PHASE2/PHASE3